quinoxalines has been researched along with Infections, Proteus in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Almazov, AS; Fridental', MA; Mikhaĭlichenko, VA; Sinepupov, NA; Taranenko, LD | 1 |
Bambury, RE; Edwards, ML; Ritter, HW | 2 |
3 other study(ies) available for quinoxalines and Infections, Proteus
Article | Year |
---|---|
[Intensive treatment of patients with surgical sepsis by means of dioxidine and hemosorption].
Topics: Adult; Aged; Bacterial Infections; Escherichia coli Infections; Female; Hemoperfusion; Humans; Male; Middle Aged; Postoperative Complications; Proteus Infections; Quinoxalines; Staphylococcal Infections; Surgical Wound Infection | 1983 |
3-Substituted 2-formylquinoxaline 1,4-dioxides.
Topics: Animals; Cyclic N-Oxides; Mice; Proteus Infections; Proteus mirabilis; Quinoxalines; Salmonella Infections, Animal; Salmonella paratyphi B; Staphylococcal Infections | 1975 |
Beta-lactam antibiotics with N-oxide side chains. 1. Quinoxaline N-oxides.
Topics: Animals; Cyclic N-Oxides; Mice; Microbial Sensitivity Tests; Penicillins; Proteus Infections; Proteus mirabilis; Pseudomonas aeruginosa; Pseudomonas Infections; Quinoxalines; Salmonella paratyphi B; Staphylococcus aureus | 1976 |